Mohd. Imran K. Khan

Also affiliated with Cornell University, Mankind Pharma (India), Weill Cornell Medicine

Biochemistry, Genetics and Molecular BiologyEngineeringMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer”.

Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer

Nature Communications(2024)10.1038/s41467-024-53874-2

N/A

0.464DataRank · unranked

16 citations

Juan F. Linares, Tania Cid-Diaz, Ángeles Durán, Mohd. Imran K. Khan, Marta Osrodek +17 more